免疫系统
医学
免疫疗法
肿瘤微环境
免疫逃逸
疾病
癌症免疫疗法
癌症
癌症研究
生物信息学
癌症治疗
机制(生物学)
肿瘤细胞
神经科学
药物开发
评论文章
免疫学
计算生物学
药品
药物输送
癌细胞
心理干预
免疫检查点
炎症
癌症治疗
作者
Tianyu Zheng,Xinran Yu,Caihong Yu,Wangting Xu,Zhuoyang Fan,Yongjie Zhou,Changyu Li,Juncheng Wan,Chaoqiao Jin,Xuran Jin,Wen Zhang,Zhiping Yan,Peng Luo,Bufu Tang,Qu Xu
标识
DOI:10.1186/s40364-025-00883-y
摘要
The tumor microenvironment (TME) is a key factor influencing carcinogenesis, disease progression, and therapeutic outcomes. Tumor-associated endothelial cells (TECs), integral components of the TME, form the structural and functional foundation of the vasculature, while also modulating tumor immune responses. TECs regulate immune cell activity and distribution through multiple molecular mechanisms, thereby influencing tumor immunity. Recent evidence highlights TEC-targeted interventions as a promising strategy to enhance immunotherapy efficacy. This review examines the mechanisms through which TECs drive tumorigenesis, progression, and metastasis, and explores the therapeutic potential of TEC-targeted approaches in cancer treatment. It also provides a systematic analysis of TECs’ impact on the immune microenvironment, assessing the potential of TEC-directed therapies to overcome chemoresistance and immunotherapy resistance, thus offering new perspectives for drug development targeting TECs. Finally, the review critically evaluates potential molecular targets within TECs and recent advancements in genetic research for cancer therapy, emphasizing key research priorities and pressing clinical challenges that require urgent focus.
科研通智能强力驱动
Strongly Powered by AbleSci AI